PA
NVO

Pinnacle Associates’s Novo Nordisk NVO Stock Holding History

Pinnacle Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Sell
47,880
-22,611
-32% -$1.07M 0.02% 417
2025
Q4 		$3.59M Buy
70,491
+19,469
+38% +$996K 0.05% 298
2025
Q3 		$2.83M Buy
51,022
+14,660
+40% +$858K 0.04% 341
2025
Q2 		$2.51M Sell
36,362
-6,168
-15% -$420K 0.04% 348
2025
Q1 		$2.95M Buy
42,530
+1,063
+3% +$87.8K 0.04% 320
2024
Q4 		$3.57M Buy
41,467
+8,437
+26% +$912K 0.05% 286
2024
Q3 		$3.42M Sell
33,030
-692
-2% -$92.3K 0.06% 277
2024
Q2 		$4.81M Sell
33,722
-114
-0.3% -$15.1K 0.08% 247
2024
Q1 		$4.34M Buy
33,836
+806
+2% +$95.9K 0.07% 259
2023
Q4 		$3.42M Buy
33,030
+448
+1% +$44.3K 0.06% 280
2023
Q3 		$2.96M Sell
32,582
-11,740
-26% -$1.03M 0.06% 292
2023
Q2 		$3.59M Sell
44,322
-840
-2% -$68.6K 0.06% 269
2023
Q1 		$3.59M Buy
45,162
+368
+0.8% +$26.1K 0.07% 234
2022
Q4 		$3.03M Buy
44,794
+1,700
+4% +$99.7K 0.07% 252
2022
Q3 		$2.15M Sell
43,094
-1,820
-4% -$97.5K 0.05% 276
2022
Q2 		$2.5M Sell
44,914
-3,560
-7% -$198K 0.05% 278
2022
Q1 		$2.69M Sell
48,474
-2,740
-5% -$141K 0.05% 296
2021
Q4 		$2.87M Buy
51,214
+4,460
+10% +$242K 0.05% 291
2021
Q3 		$2.24M Buy
46,754
+13,440
+40% +$650K 0.04% 324
2021
Q2 		$1.4M Sell
33,314
-630
-2% -$24.4K 0.03% 382
2021
Q1 		$1.14M Sell
33,944
-4,390
-11% -$156K 0.02% 397
2020
Q4 		$1.34M Sell
38,334
-4,710
-11% -$163K 0.03% 360
2020
Q3 		$1.49M Sell
43,044
-200
-0.5% -$6.67K 0.04% 317
2020
Q2 		$1.42M Buy
43,244
+460
+1% +$14.7K 0.03% 322
2020
Q1 		$1.29M Buy
42,784
+356
+0.8% +$10.6K 0.04% 307
2019
Q4 		$1.23M Sell
42,428
-2,000
-5% -$55.4K 0.03% 369
2019
Q3 		$1.15M Sell
44,428
-718
-2% -$18.2K 0.03% 376
2019
Q2 		$1.15M Sell
45,146
-1,820
-4% -$45K 0.03% 383
2019
Q1 		$1.23M Sell
46,966
-2,624
-5% -$64.5K 0.03% 372
2018
Q4 		$1.14M Sell
49,590
-76,940
-61% -$1.71M 0.03% 372
2018
Q3 		$2.98M Sell
126,530
-9,144
-7% -$223K 0.06% 269
2018
Q2 		$3.13M Sell
135,674
-27,672
-17% -$658K 0.06% 263
2018
Q1 		$4.02M Sell
163,346
-11,798
-7% -$310K 0.08% 238
2017
Q4 		$4.7M Sell
175,144
-5,862
-3% -$149K 0.09% 216
2017
Q3 		$4.36M Buy
181,006
+9,432
+5% +$213K 0.08% 221
2017
Q2 		$3.68M Buy
171,574
+7,942
+5% +$160K 0.07% 239
2017
Q1 		$2.81M Sell
163,632
-12,980
-7% -$226K 0.05% 274
2016
Q4 		$3.17M Sell
176,612
-18,306
-9% -$332K 0.06% 255
2016
Q3 		$4.05M Sell
194,918
-27,902
-13% -$692K 0.08% 225
2016
Q2 		$5.99M Sell
222,820
-10,930
-5% -$300K 0.13% 170
2016
Q1 		$6.33M Sell
233,750
-7,704
-3% -$206K 0.14% 162
2015
Q4 		$7.01M Sell
241,454
-2,880
-1% -$79.7K 0.15% 149
2015
Q3 		$6.63M Sell
244,334
-2,344
-1% -$66.4K 0.15% 159
2015
Q2 		$6.75M Buy
246,678
+8,954
+4% +$252K 0.13% 166
2015
Q1 		$6.35M Buy
237,724
+9,110
+4% +$210K 0.12% 174
2014
Q4 		$4.84M Buy
228,614
+37,068
+19% +$828K 0.09% 197
2014
Q3 		$4.56M Buy
191,546
+4,760
+3% +$110K 0.09% 200
2014
Q2 		$4.31M Sell
186,786
-6,570
-3% -$145K 0.08% 201
2014
Q1 		$4.41M Sell
193,356
-31,074
-14% -$662K 0.09% 191
2013
Q4 		$4.15M Buy
224,430
+51,270
+30% +$894K 0.08% 207
2013
Q3 		$2.93M Buy
173,160
+72,000
+71% +$1.21M 0.06% 231
2013
Q2 		$1.57M Buy
+101,160
New +$1.68M 0.04% 294

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Pinnacle Associates's NVO Position: Q1 2026 in Review

Pinnacle Associates reduced its Novo Nordisk (NVO) stake by 32% in Q1 2026, selling an estimated $1.07M and leaving 47,880 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #417.

Pinnacle Associates first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.01M in Q4 2015. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Pinnacle Associates held 47,880 shares of Novo Nordisk worth $1.76M as of Q1 2026.
  • Pinnacle Associates sold 22,611 Novo Nordisk shares in Q1 2026, an estimated $1.07M.
  • Novo Nordisk made up 0.02% of Pinnacle Associates's portfolio in Q1 2026, its #417 holding.
  • Pinnacle Associates first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Pinnacle Associates's Novo Nordisk position peaked at $7.01M in Q4 2015.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.